Envision Healthcare Co. (NYSE:EVHC) – Investment analysts at Oppenheimer lifted their Q1 2018 earnings per share estimates for Envision Healthcare in a research report issued to clients and investors on Tuesday. Oppenheimer analyst M. Wiederhorn now forecasts that the company will post earnings of $0.51 per share for the quarter, up from their previous forecast of $0.49. Oppenheimer currently has a “Outperform” rating and a $40.00 price objective on the stock.

EVHC has been the topic of several other reports. Citigroup lowered shares of Envision Healthcare from a “buy” rating to a “neutral” rating and set a $31.00 price target on the stock. in a research note on Thursday, November 2nd. Bank of America cut their price target on shares of Envision Healthcare from $72.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, October 9th. Piper Jaffray Companies began coverage on shares of Envision Healthcare in a research note on Wednesday, December 13th. They set a “neutral” rating and a $35.00 price target on the stock. KeyCorp cut their price target on shares of Envision Healthcare from $67.00 to $37.00 and set an “overweight” rating on the stock in a research note on Thursday, November 2nd. Finally, Canaccord Genuity reiterated a “buy” rating and set a $32.00 price target (down from $68.00) on shares of Envision Healthcare in a research note on Thursday, November 2nd. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and nine have issued a buy rating to the company’s stock. Envision Healthcare currently has an average rating of “Hold” and a consensus target price of $40.73.

Shares of Envision Healthcare (NYSE EVHC) traded down $0.25 during trading hours on Thursday, reaching $34.81. 2,883,200 shares of the company traded hands, compared to its average volume of 2,570,436. Envision Healthcare has a 12-month low of $23.77 and a 12-month high of $73.00. The company has a debt-to-equity ratio of 0.89, a current ratio of 3.01 and a quick ratio of 3.00. The firm has a market cap of $4,210.00, a price-to-earnings ratio of -23.36, a P/E/G ratio of 0.92 and a beta of 0.57.

Envision Healthcare (NYSE:EVHC) last announced its quarterly earnings data on Tuesday, October 31st. The company reported $0.73 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.81 by ($0.08). Envision Healthcare had a negative net margin of 6.39% and a positive return on equity of 4.88%. The firm had revenue of $1.99 billion during the quarter, compared to analyst estimates of $2.03 billion. During the same quarter in the previous year, the business posted $1.13 earnings per share. Envision Healthcare’s revenue for the quarter was up 142.0% compared to the same quarter last year.

A number of institutional investors have recently modified their holdings of EVHC. JPMorgan Chase & Co. grew its position in Envision Healthcare by 76.8% during the 2nd quarter. JPMorgan Chase & Co. now owns 113,879 shares of the company’s stock worth $7,136,000 after purchasing an additional 49,479 shares during the last quarter. Commonwealth Bank of Australia grew its position in Envision Healthcare by 24.3% during the 2nd quarter. Commonwealth Bank of Australia now owns 2,096 shares of the company’s stock worth $130,000 after purchasing an additional 410 shares during the last quarter. Riverhead Capital Management LLC grew its position in Envision Healthcare by 17.0% during the 2nd quarter. Riverhead Capital Management LLC now owns 7,000 shares of the company’s stock worth $439,000 after purchasing an additional 1,017 shares during the last quarter. TIAA CREF Investment Management LLC grew its position in Envision Healthcare by 11.1% during the 2nd quarter. TIAA CREF Investment Management LLC now owns 819,032 shares of the company’s stock worth $51,329,000 after purchasing an additional 82,054 shares during the last quarter. Finally, Norinchukin Bank The grew its position in Envision Healthcare by 6.8% during the 2nd quarter. Norinchukin Bank The now owns 8,151 shares of the company’s stock worth $511,000 after purchasing an additional 519 shares during the last quarter.

TRADEMARK VIOLATION NOTICE: This story was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://www.americanbankingnews.com/2018/01/18/q1-2018-eps-estimates-for-envision-healthcare-co-evhc-raised-by-analyst.html.

About Envision Healthcare

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.